Drug recalls, alerts, and new therapies

Find the up-to-date information that you need right here, including pharmacy-related safety alerts, drug recalls, new therapies and generics, and other medication information.

Drug alerts

01/14/2014
Detrol LA® is available as a generic
We want to let you know Detrol LA® is now available as a generic. Detrol LA® treats patients with an overactive bladder.
Detrol LA® (96Kb)

01/02/2014
Cymbalta
We want to let you know Cymbalta® is now available as a generic.
Cymbalta (96Kb)

12/19/2013
FreeStyle Test Strips Recall
The manufacturer of FreeStyle and FreeStyle Lite Blood Glucose Test Strips is recalling these items because when used with the FreeStyle Blood Glucose Meter or the FreeStyle Flash Blood Glucose Meter they can show glucose readings that are lower than they really are.
FreeStyle and FreeStyle Lite Blood Glucose Test Strips Recalled (99.5Kb)

03/26/2013
Atorvastatin Drug Recall
The manufacturer of atorvastatin has issued a voluntary recall of certain lots of this medicine.
Atorvastatin recalled (25Kb)

03/26/2013
Pradaxa Drug Recall
The manufacturer of Pradaxa is recalling one lot of Pradaxa due to a potential packaging defect.
Pradaxa recalled (300Kb)

03/26/2013
Generic Suboxone Available
Suboxone is now available as a generic.
Suboxone is available as a generic (93Kb)

09/14/2012
Actos and ActoPlus Met are available as generics (pioglitazone and pioglitazone/metformin)
We want to let you know Actos and ActoPlus Met are now available as generics, pioglitazone and pioglitazone/metformin. Actos and the combination drug ActoPlus Met are used to treat patients with type 2 diabetes.
Actos and ActoPlus Met are available as generics (166Kb)

09/14/2012
Packages of Nimodipine Capsules, 30 mg Recalled
The manufacturer of Nimodipine is recalling certain packages of the medicine due to the discovery that some capsules may contain crystallized material.
Packages of Nimodipine Capsules, 30 mg Recalled (77Kb)

08/24/2012
Singulair is available as a generic (montelukast)
We want to let you know Singulair is now available as a generic. Singulair treats asthma and allergies.
Singulair is available as a generic (165Kb)

08/24/2012
Detrol is available as a generic (tolterodine)
We want to let you know Detrol is now available as a generic. Detrol treats patients with overactive bladder. Ask your doctor or pharmacist if the generic, tolterodine, is right for you.
Detrol is available as a generic (167Kb)

06/15/2012
Introvale (levonorgestrel and ethinyl estradiol) Packages Recalled
The manufacturer of Introvale is recalling certain packages of the medicine due to the discovery that the active pills (which are a peach color) and placebo pills (which are white) in some packs may be in the wrong order.
Introvale (levonorgestrel and ethinyl estradiol) Packages Recalled (98Kb)

6/8/2012
Gilenya (fingolimod) Can Cause Serious Side Effects, Including Slow Heart Rate
According to the U.S. Food and Drug Administration (FDA), using Gilenya (fingolimod) can cause serious side effects such as slow heart rate (bradycardia), which can lead to dizziness, fatigue, and heart palpitations. Gilenya is a medicine that is used to treat relapsing forms of multiple sclerosis, also known as MS.
Your Medicine May Cause Side Effects (150.61Kb)

06/01/2012
Plavix is Available as a Generic (Clopidogrel)

Plavix is now available as a generic called clopidogrel. Plavix is used to help prevent blood platelets from forming clots in people who have heart disease or poor circulation, usually in the legs (also called peripheral artery disease). Plavix is also prescribed to people who have had a recent heart attack or stroke.
Plavix is Available as a Generic (Clopidogrel) (166.5Kb)

05/25/2012
Certain Packages of Hydromorphone Injection Recalled
Certain packages of hydromorphone injection USP, 1 mg/mL, 1 mL fill in 2.5 mL Carpuject have been recalled by its manufacturer, Hospira Inc.
Packages of Hydromorphone Injection Recalled (77Kb)

05/04/2012
Certain packages of morphine sulfate injection USP, 4 mg/mL, 1 mL fill recalled
The manufacturer of morphine sulfate injection is recalling certain packages of the medicine due to a consumer report of two Carpuject syringes that had more than 1 mL of morphine sulfate.
Packages of Morphine Sulfate Injection Recalled (76Kb)

04/19/2012
FDA Revises Safety Labels for Statins
The U.S. Food and Drug Administration (FDA) revised the safety labels on statins, a class of medicines aimed at lowering cholesterol. The new information includes: memory loss and confusion have been reported with statin use; increases in blood sugar levels have been reported with statin use; liver enzyme tests should be performed before starting statin therapy and as recommended by your doctor.
FDA Revises Safety Labels for Statins (150Kb)

04/19/2012
Aliskiren Products (Tekturna®, Tekturna HCT®, Takamlo®, Valturna®, and Amturnide®) No Longer Recommended for Diabetic Patients also on an ACEI or ARB
The use of medicines that contain aliskiren with an ACEI or ARB can increase the risk of kidney problems, low blood pressure, and increased potassium levels.
Aliskiren Products (Tekturna®, Tekturna HCT®, Takamlo®, Valturna® and Amturnide®) No Longer Recommended for Diabetic Patients also on an ACEI or ARB (27Kb)

03/05/2012
Packages of Norgestimate and Ethinyl Estradiol Recalled
The manufacturer of norgestimate and ethinyl estradiol is recalling certain packages of the medicine due to the discovery that some packs may have tablets that are out of sequence.
Packages of Norgestimate and Ethinyl Estradiol Recalled (112Kb)

03/01/2012
Proton Pump Inhibitors (PPIs) May Increase Risk of Clostridium difficile-Associated Diarrhea (CDAD)
According to the U.S. Food and Drug Administration (FDA), using proton pump inhibitors (PPIs) may increase the risk of Clostridium difficile-associated diarrhea (CDAD).
Proton Pump Inhibitors (PPIs) May Increase Risk of Clostridium difficile-Associated Diarrhea (CDAD) (27Kb)

03/01/2012
FDA Issues Warning about Counterfeit Avastin®
According to the U.S. Food and Drug Administration (FDA), a counterfeit version of Avastin 400 mg/16 mL may have been bought and administered in 19 medical practices in the United States.
FDA Issues Warning about Counterfeit Avastin® (26Kb)

02/20/2012
Vials of Acetylcysteine Solution 20 Percent, 30 mL Recalled
Lot Number 1877093 of acetylcysteine solution 20 Percent, 30 mL vials has been recalled by its manufacturer due to the discovery of a visible glass particle in a vial within this lot.
Vials of Acetylcysteine Solution 20%, 30 mL Recalled (24Kb)

02/10/2012
Norvatis Consumer Health suspends production of Endo Pharmaceuticals products Opana® ER, Opana®, oxymorphone hydrochloride, Percocet®, Percodan®, Endocet®, Endodan®, morphine sulfate extended–release, and Zydone®.
The manufacturer of Opana® ER, Opana®, oxymorphone hydrochloride, Percocet®, Percodan®, Endocet®, Endodan®, morphine sulfate extended–release, and Zydone® is suspending production due to a potential product mix-up in which tablets from one medicine may have been placed into packaging of another medicine.
Opana® ER, Opana®, Oxymorphone Hydrochloride, Percocet®, Percodan®, Endocet®, Endodan®, Morphine Sulfate Extended–Release, and Zydone® suspended from production (184Kb)

02/10/2012
Pfizer Inc. recalls packages of Lo/Ovral®-28 and norgestrel/ethinyl estradiol.
The manufacturer of Lo/Ovral®-28 and norgestrel/ethinyl estradiol is recalling certain packages of the medicine due to the discovery that some packs may have the wrong number of active and inactive ingredient tablets and that the tablets may be out of sequence.
Packages of Lo/Ovral® and Norgestrel/Ethinyl Estradiol Recalledl (110Kb)

11/17/2011
Zyprexa® is now available as a generic.
Zyprexa® is available as a generic (169Kb)

11/1/2011
According to the U.S. Food and Drug Administration (FDA), Avandia (a rosiglitazone-containing product), will no longer be dispensed through your local pharmacy effective November 18, 2011.
Avandia® May Cause Side Effects (150Kb)

10/13/2011
According to the U.S. Food and Drug Administration (FDA), using repackaged Avastin® (bevacizumab) for eye injections can cause serious eye infections in rare cases.
Your Medicine May Cause Side Effects (32Kb)

10/13/2011
According to the FDA, using the antidepressant Celexa can lead to a rare ventricular tachycardia.
Your Medicine May Cause Side Effects (32Kb)

10/13/2011
According to the FDA, using Reclast can lead to severe kidney failure in rare cases.
Your Medicine May Cause Side Effects (32Kb)

8/19/2011
According to the U.S. Food and Drug Administration (FDA), using Zyvox (linezolid) and psychiatric medications affecting serotonin levels, can cause side effects.
Your Medicine May Cause Side Effects (26Kb)

8/11/2011
Arixtra® is now available as a generic.
Arixtra® is available as a generic (165Kb)

8/11/2011
Tamiflu® May Cause Side Effects
Tamiflu® May Cause Side Effects (166Kb)

8/11/2011
Valproate Medications May Cause Side Effects
Valproate Medications May Cause Side Effects (152Kb)

7/28/2011
Possible side effects of using Erythropoiesis-Stimulating Agents
According to the FDA, using Erythropoiesis-Stimulating Agents such as Procrit®, Epogen®, or Aranesp® for the treatment of anemia in patients with chronic kidney disease can cause an increased risk of harmful side effects.
Your Medicine May Cause Side Effects (148Kb)

7/15/2011
Recall of some butalbital, acetaminophen and caffeine tablets
The manufacturer of butalbital, acetaminophen and caffeine tablets is recalling some bottles of this medicine after a single bottle of tablets was found incorrectly labeled.
Butalbital, Acetaminophen and Caffeine Tablets Recalled (23Kb)

7/15/2011
Recall of some Endocet® 10/325 mg tablets
The manufacturer of Endocet® 10/325 mg tablets is recalling some bottles of this medicine because some bottles may contain different strength tablets.
Endocet® 10/325 mg Tablets Recalled (26Kb)

7/15/2011
Recall of some hydrocodone and acetaminophen tablets
The manufacturer of hydrocodone and acetaminophen tablets is recalling some bottles of this medicine after a single bottle of tablets was found incorrectly labeled.
Hydrocodone and Acetaminophen Tablets recalled (23Kb)

7/15/2011
The FDA says Simvastatin (Zocor) 80mg may cause muscle injury.
Your Medicine May Cause Side Effects (105Kb)

6/30/2011
Humana Changes Coverage for Medicines
Effective September 1, 2011, Humana will require Prior Authorization (PA) for some medicines across certain Medicare formularies.
Humana Changes Coverage for Medicines (16Kb)

6/24/2011
Ropinirole 1 mg tablets recalled
One lot of Ropinirole 1 mg tablets has been recalled by its manufacturer CorePharma LLC.
Ropinirole 1 mg tablets recalled (23Kb)

6/24/2011
Glyburide 2.5 mg tablets recalled
One lot of Glyburide 2.5 mg tablets has been recalled by its manufacturer CorePharma LLC.
Glyburide 2.5 mg tablets recalled (23Kb)

5/20/2011
Allegra® and Allegra-D® are now available without a prescription
Allegra® (fexofenadine) and Allegra-D® (fexofenadine/pseudoephedrine) are now available over-the-counter (OTC) and may be purchased without a prescription.
(39 KB) Download PDF
Allegra® (fexofenadine) Available Over-The-Counter (39Kb)

5/20/2011
Important Recall Notice Regarding using tumor necrosis factor (TNF) blockers
According to the U.S. Food and Drug Administration (FDA), using tumor necrosis factor (TNF) blockers (medicines like Humira®, Enbrel®, Simponi®, Cimzia®, Remicade®) , azathioprine, and/or mercaptopurine can cause side effects.
Your Medicine May Cause Side Effects (32Kb)

5/20/2011
Important Recall Notice Regarding Coumadin
One lot number of Coumadin 5 mg tablets has been recalled by its manufacturer, Bristol-Myers Squibb because a single tablet was found to be higher in potency than expected.
Coumadin® (warfarin sodium) 5 mg Tablets Recalled (28Kb)

4/28/2011
PPI extended usage causes unwanted side effects
According to the U.S. Food and Drug Administration (FDA), using Proton Pump Inhibitors (Nexium, Prevacid, Prilosec, etc) for an extended period of time may cause low magnesium levels.
Your Medicine May Cause Side Effects (32Kb)

4/28/2011
Xalatan now is available in generic form-latanoprost.
Xalatan®, a drug approved to help with the treatment of glaucoma, is now available as a generic, latanoprost.
Xalatan® is Available as a Generic (57Kb)

4/15/2011
Auralgan Otic Solution Removed From The Market
The FDA notified companies that make, ship, or sell Auralgan Otic Solution to stop. This is because the medicine does not have FDA approval and its labeling does not include adequate directions. This means Auralgan Otic Solution will no longer be available.
Auralgan Otic Solution Removed From The Market (57Kb)

4/1/2011
Embeda has been recalled by its manufacturer King Pharmaceuticals Inc.
The manufacturer of Embeda is recalling this product due to a pre-specified stability requirement not met during routine testing.
Embeda® (morphine sulfate and naltrexone hydrochloride) Recalled (57Kb)

4/1/2011 Taxotere® is available as a generic
Taxotere®, a drug approved for certain cancers, is now available as a generic, docetaxel.
Taxotere® is Available as a Generic (11Kb)

2/25/2011
Lipitor® recalled
Pfizer has recalled several lots of Lipitor® 40 mg (atorvastatin calcium) after a small number of reports of an uncharacteristic odor associated with the plastic bottles used to package the product. The FDA has noted that health risks associated with the cause of this recall to be minimal.
Lipitor® recalled (11Kb)

2/25/2011
Meridia® (sibutramine) Removed From The Market
The FDA asked Abbott Laboratories, the company that makes Meridia® (sibutramine), to voluntarily remove the drug from the U.S. market immediately. This is due to clinical trial data indicating an increased risk of cardiovascular adverse events, including heart attack and stroke in the studied population. This means Meridia® (sibutramine) will no longer be available.
Meridia® (sibutramine) Removed From The Market (78Kb)

02/25/11
Aricept® is Available as a Generic

Aricept®, a drug used for dementia associated with Alzheimer's disease, or other causes, is now available as a generic, rivastigmine tartrate.
Aricept® is Available as a Generic (68Kb)

01/11/11
Hydrocodone and Acetaminophen 10mg / 500mg Tablets and Phenobarbital 32.4mg Tablets Voluntarily Recalled
Qualitest Pharmaceuticals issued a voluntary nationwide recall of hydrocodone and acetaminophen tablets 10mg / 500mg and phenobarbital tablets 32.4 mg. An individual bottle of hydrocodone and acetaminophen tablets, 10mg / 500mg, 60 count was found incorrectly labeled with a phenobarbital tablets 32.4mg, 1000 count label.
Hydrocodone and Acetaminophen 10mg / 500mg Tablets and Phenobarbital 32.4mg Tablets Voluntarily Recalled (60Kb)